Management of bleeding events and invasive procedures in patients with haemophilia A without inhibitors treated with emicizumab: A consensus statement of the Working Party on Haemostasis of the Swiss Society of Haematology and the Swiss Haemophilia Network. Swiss Med Wkly [Internet]. 2020 Dec. 18 [cited 2025 Oct. 14];150(5153):w20422. Available from: https://www.smw.ch/index.php/smw/article/view/2933